Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Grant | Design: Display screen with graphical user interface Filling date: 23 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Design: Display screen with graphical user interface Filling date: 23 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Vitreoretinal instruments for fluid aspiration Filling date: 23 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Methods and system for imaging an inner limiting membrane using a stain Filling date: 23 Sep 2025 Issue date: 15 Jun 2021 |
Application | Utility: FGF21 Mimetic Antibodies and Uses Thereof Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANTIGEN RECEPTOR THERAPY AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Pharmaceutical Composition Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR?EXPRESSING CELLS Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Method for producing MPS-compatible water gradient contact lenses Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Method for producing MPS-compatible water gradient contact lenses Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules Filling date: 23 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Octreotide Depot Formulation with Constantly High Exposure Levels Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: IMMUNOSUPPRESSANT FORMULATION Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: COMBINATION THERAPY FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Compositions and methods for modulating farnesoid X receptors Filling date: 23 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Vitrectomy probe with rotational helical cutter Filling date: 23 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: Ceritinib Formulation Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: POLYMERIC DRUG CONJUGATES WITH TETHER GROUPS FOR CONTROLLED DRUG DELIVERY Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS TO TREAT CANCER Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR TREATING SOLID TUMORS BY INTRATUMORAL ADMINISTRATION Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Grant | Utility: Lipids and lipid compositions for the delivery of active agents Filling date: 23 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Methods of Using IL-1beta Compounds Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: NEW THERAPEUTIC USES Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: LICOFLIGOZIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Grant | Utility: 3' end caps for RNAi agents for use in RNA interference Filling date: 23 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Pixelated array optics for mixed mode surgical laser illumination Filling date: 23 Sep 2025 Issue date: 18 May 2021 |
Application | Utility: TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: CD19 BINDING MOLECULES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Grant | Utility: Ceritinib formulation Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Multifocal ophthalmic lens having chromatic aberration correction Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Multifocal diffractive ophthalmic lens Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Multifocal diffractive ophthalmic lens using suppressed diffractive order Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Soft silicone medical devices Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Intraocular lens injector Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Method for applying stable coating on silicone hydrogel contact lenses Filling date: 23 Sep 2025 Issue date: 11 May 2021 |
Application | Utility: Drug Delivery Systems Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Showing 400 to 450 of 1223 patents.